EUVIMEDEUVIMED entdecken
Crossref

Methylseleninic acid overcomes gefitinib resistance through asparagine-MET-TOPK signaling axis in non-small cell lung cancer cells

Jinling Cui, Shuang Zhao, Hui Chen, Yuhan Fu, Kai Han, Shutao Yin, Chong Zhao, Lihong Fan, Hongbo Hu

Biochemical Pharmacology · 2023-09 · 215 · 115690

DOI: 10.1016/j.bcp.2023.115690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2023-09. Verfasst von Jinling Cui und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Nutritional Engineering, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, No.17 Qin…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Key Research and Development Program of China, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acquired resistance compromises the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-based therapy for non-small cell lung cancer (NSCLC), and activation of hepatocyte growth factor receptor (MET) is one of the pivotal strategies for cancer cells to acquire refractory phenotype. However, the mechanisms involved in regulating MET activity remain to be further elucidated. Using gefitinib-resistant HCC827GR cell line as a model, we unraveled that the dysregulated amino acid metabolisms reflected by elevated expression of cysteine-preferring transporter 2 (ASCT2), cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11) and asparagine synthetase (ASNS) might contribute to survival advantage of HCC827GR cells, and rendered the cells more sensitive to asparagine (ASN) deprivation compared to parental HCC827 cells. We further identified that the increased ASNS expression is a contributing factor for the activation of MET in HCC827GR cells. More importantly, we found that methylseleninic acid (MSeA), a precursor of methylselenol, effectively suppressed tumor growth in HCC827GR xenograft model, which is associated with decrease of intracellular ASN content along with inactivation of MET- T-lymphokine-activated killer cell-originated protein kinase (TOPK) signaling axis. Finally, we demonstrated that combination of MSeA and gefitinib induced a synergistic growth inhibition in HCC827GR cells. The findings of our work reveal that ASN-MET-TOPK signaling axis as a novel mechanism contributed to gefitinib-resistance and combined utilization of gefitinib and MSeA holds potential to improve the efficacy for gefitinib-resistant NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsHumansGefitinibAsparagineErbB ReceptorsQuinazolinesDrug Resistance, NeoplasmCell Line, TumorProtein Kinase InhibitorsCell ProliferationOrganoselenium Compounds

Stichwörter der Autor:innen

AsparagineGefitinib resistanceMETMethylseleninic acidNSCLC

Substanzen

GefitinibAsparagineErbB ReceptorsQuinazolinesProtein Kinase InhibitorsAntineoplastic Agentsmethylselenic acidOrganoselenium Compounds

Autor:innen und Institutionen

  • College of Food Science and Nutritional Engineering, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, No.17 Qinghua East Road, Haidian District, Beijing 100083, China.
  • College of Food Science and Nutritional Engineering, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, No.17 Qinghua East Road, Haidian District, Beijing 100083, China. Electronic ad…
  • College of Veterinary Medicine, China Agricultural University, No.2 Yunamingyuan West Road, Haidian District, Beijing 100193, China. Electronic address: flh@cau.edu.cn.

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Key Research and Development Program of China
  • Chinese Academy of Sciences
  • Institute of Biophysics, Chinese Academy of Sciences

Zitieren

APA

Cui, J., Zhao, S., Chen, H., Fu, Y., Han, K., Yin, S., Zhao, C., Fan, L., & Hu, H. (2023). Methylseleninic acid overcomes gefitinib resistance through asparagine-MET-TOPK signaling axis in non-small cell lung cancer cells. Biochemical Pharmacology, 215, 115690. https://doi.org/10.1016/j.bcp.2023.115690

Vancouver

Cui J, Zhao S, Chen H, Fu Y, Han K, Yin S, et al. Methylseleninic acid overcomes gefitinib resistance through asparagine-MET-TOPK signaling axis in non-small cell lung cancer cells. Biochemical Pharmacology. 2023;215:115690. doi:10.1016/j.bcp.2023.115690

BibTeX
@article{Cui2023,
  author = {Cui, Jinling and Zhao, Shuang and Chen, Hui and Fu, Yuhan and Han, Kai and Yin, Shutao and Zhao, Chong and Fan, Lihong and Hu, Hongbo},
  title = {Methylseleninic acid overcomes gefitinib resistance through asparagine-MET-TOPK signaling axis in non-small cell lung cancer cells},
  journal = {Biochemical Pharmacology},
  year = {2023},
  volume = {215},
  pages = {115690},
  doi = {10.1016/j.bcp.2023.115690}
}
Kostenlos starten →